References:
  1. Zhou Y, Zhang J. Arthrogryposis-renal dysfunction-cholestasis (ARC) syndrome: from molecular genetics to clinical features. Ital J Pediatr. 2014;40: 77.
  2. Del Brío Castillo R, Squires JE, McKiernan PJ. A novel mutation in VPS33B gene causing a milder ARC syndrome phenotype with prolonged survival. JIMD Rep. 2019;47: 4–8.
  3. Agawu A, Sheppard S, Lin HC. A Novel VPS33B Mutation Causing a Mild Phenotype of Arthrogryposis, Renal dysfunction, and Cholestasis Syndrome. J Pediatr Gastroenterol Nutr. 2019;69: e55–e56.
  4. Agakidou E, Agakidis C, Kambouris M, Printza N, Farini M, Vourda E, et al. A Novel Mutation of VPS33B Gene Associated with Incomplete Arthrogryposis-Renal Dysfunction-Cholestasis Phenotype. Case Rep Genet. 2020;2020: 8872294.
  5. Li L-T, Zhao J, Chen R, Wang J-S. Two novel VPS33B mutations in a patient with arthrogryposis, renal dysfunction and cholestasis syndrome in mainland China. World J Gastroenterol. 2014;20: 326–329.
  6. Taha D, Khider A, Cullinane AR, Gissen P. A novel VPS33B mutation in an ARC syndrome patient presenting with osteopenia and fractures at birth. Am J Med Genet A. 2007;143A: 2835–2837.